1. Illumina CEO Jay Flatley Sells $4,533,500 in $ILMN http://www.analystratings.net/stocks/NASDAQ/ILMN/?RegistrationCode=SocialMedia-direct&DefaultTab=Insider

  2. $ILMN vs. $MTD vs. $A Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=ILMN|MTD|A|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  3. Illumina s Chief Executive Officer just cashed-in 25,000 options http://www.conferencecalltranscripts.org/4/summary/?id=1577912 $ILMN

  4. $ILMN: New Insider Transaction on ILMN by Chief Executive Officer FLATLEY JAY T: http://insideri.com/1189130_000111080315000111_0001110803-15-000111

  5. Illumina s buy rating reiterated at Zacks. $210.00 PT. http://www.analystratings.net/stocks/NASDAQ/ILMN/?RegistrationCode=SocialMedia-direct $ILMN

  6. $ILMN EPS is Improving. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ILMN&financial_bar=EPS+-+Net(Diluted)+TTM+&financial_line=EPS+-+Net(Diluted)+TTM+&start_date=03/31/2000&end_date=12/28/2014&show_line=false&sk=c36d43a4fcfd9de2997caddf91158fd0

  7. $ILMN vs. $A vs. $WAT vs. $Q Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=ILMN|A|WAT|Q|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  8. $ILMN Revenue is Rising. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ILMN&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=03/31/2000&end_date=12/28/2014&show_line=false&sk=c36d43a4fcfd9de2997caddf91158fd0

  9. another European Partner for $SQNM $ILMN patent pool: http://reference-laboratory.es/pag/pagina.php?p=SERVICIOS&s=NOV … Reference signs agreement with US Illumina for #NIPT

  10. breaking: effective april13 $DGX Quest will start offering its QNatal Advance #NIPT test + pay license fees into $SQNM / $ILMN patent pool

  11. breaking: effective aprli13 $DGX Quest will start offering its QNatal Advance #NIPT test + pay license fees into $SQNM / $ILMN patent pool

  12. $ILMN Needs to get back over 195

  13. $ILMN ---> Like. Bounce off 200 DMA. Might head to 195.

  14. @OphirGottlieb: $ILMN EPS is Improving. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ILMN&financial_bar=EPS+-+Net(Diluted)+TTM+&financial_line=EPS+-+Net(Diluted)+TTM+&start_date=03/31/2000&end_date=12/28/2014&show_line=false&sk=c36d43a4fcfd9de2997caddf91158fd0

  15. $ILMN EPS is Improving. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ILMN&financial_bar=EPS+-+Net(Diluted)+TTM+&financial_line=EPS+-+Net(Diluted)+TTM+&start_date=03/31/2000&end_date=12/28/2014&show_line=false&sk=c36d43a4fcfd9de2997caddf91158fd0

  16. $ILMN high open interest range is 185.00 to 195.00 for option expiration 03/27/2015. http://maximum-pain.com/open-interest.aspx?s=ILMN&e=03/27/2015

  17. $ILMN Max Pain = 187.50. Maturity = 03/27/2015. Previous close = 187.17. http://maximum-pain.com/max-pain.aspx?s=ILMN&e=03/27/2015

  18. iShares Nasdaq Biotechnology ETF $IBB +14.54% YTD Top Ten Holdings $BIIB $CELG $GILD $AMGN $REGN $ILMN $VRTX $ALXN $MYL $PCYC

  19. $SQNM Sequenom, $3.90/ is set to pop. $150m in sales, settled patent disputes and partnered w $ILMN. Unlimited potential and game changing.

  20. Slingshot Bearish http://www.dailystockplays.com/Slingshot-Bearish-2015-03-29.html $DAL $KITE $HALO $BCRX $ILMN $BAH $GEVA $ACOR $SWIR $DLB $CARA $BOBE $ENTA $CMRX $MELI $MKTO $QSII

  21. $ILMN high open interest range is 185.00 to 195.00 for option expiration 03/27/2015. http://maximum-pain.com/open-interest.aspx?s=ILMN&e=03/27/2015

  22. $ILMN Revenue is Rising. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ILMN&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=03/31/2000&end_date=12/28/2014&show_line=false&sk=c36d43a4fcfd9de2997caddf91158fd0

  23. $ILMN Max Pain = 187.50. Maturity = 03/27/2015. Previous close = 187.17. http://maximum-pain.com/max-pain.aspx?s=ILMN&e=03/27/2015

  24. A few T.A. tips and links to use for Biotech sector investing http://stockreversals.com/2015/03/29/biotech-trading-tips-and-updates-march-29th/ $syn $chrs $ibb $biib $ilmn $cldx $nvta $clls $syn

  25. $ALXN vs. $BMRN vs. $ILMN INSTANT 9 Variable Comparison >> http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=ALXN%7CBMRN%7CILMN&metrics=Revenue%20(TTM%20US%24%20Millions)%7CNet%20Income%20(TTM%20US%24%20Millions)%7CRevenue%2FNumber%20of%20Employees%20(TTM%20US%24%20Millions)%7CGross%20Margin%20%25%7CNet%20Income%20Margin%20%25%7CResearch%20and%20Development%20Expense%2FOperating%20Expense%7CRevenue%20TTM%2C%201-Year%20Growth%20%25%7CNet%20Income%20TTM%2C%201-Year%20Growth%20%25%7CPrice%20to%20Sales%20(at%20Quarter%20End)%7CNon-Performing%20Loans%2FLoans%7COperating%20Revenues%2FOperating%20Expense #CML